Bayer begins phase 3 trial testing aflibercept in infant blindness

Bayer begins phase 3 trial testing aflibercept in infant blindness

Submitted by admin on June 24, 2019 - 9:39am
Source: 
Pharmaforum
News Tags: 
Bayer
clinical trials
infant blindness
Aflibercept
retinopathy of prematurity
Headline: 
Bayer begins phase 3 trial testing aflibercept in infant blindness
snippet: 

Bayer has begun a late-stage trial of its blockbuster aflibercept eye drug to prevent blindness in premature infants.

Do Not Allow Advertisers to Use My Personal information